Emerging Technologies: Healthcare Communication Friend or Foe?
Embracing emerging technologies and innovations is not just an option but a necessity for biopharma, HCPs, and organizations looking to thrive in the digital age...
Read MoreTop Stories
Cactus Life Sciences Announces the Acquisition
FOR IMMEDIATE RELEASE Princeton, NJ, April 24, 2024 - Cactus...
Cactus Life Sciences Appoints Oliver Dennis to
Princeton, NJ, April 16, 2024 - Cactus Life Sciences, a...
Optimizing Medical Affairs with Modular Content:
Turn your organization into an “efficiency powerhouse” with...
Filter
Digital Publication Extenders: Creating an Ecosystem for a More Engaging and Informative Experience
While creating digital publication extenders may seem complex, Cactus Life Sciences can assist in developing...
The Quest for Omnichannel: Is Medical Affairs Ready?
Commercial and Medical Affairs must partner with each other to achieve the real benefits of...
Periodic Safety Update Report (PSUR): A Breakdown of MDCG 2022-21
A well-structured, clear, and concise PSUR enables a seamless notified body review. Read our key...
Why Is It Important to Include Patients as Peer Reviewers
Patient peer reviews offer an amazing opportunity to see how HCPs and pharmaceutical companies are...
Didactic to Dynamic: Innovative Approaches to Deeper Payer Engagements
HEOR is a fast-evolving field. Feedback from payers can influence research plans and help create...
Clinical Evidence: How Much Is Enough?
Ensuring the safety and functionality of your medical device is vital. But how much clinical...